Literature DB >> 24504026

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.

M Jourdan1, M Cren1, N Robert2, K Bolloré2, T Fest3, C Duperray4, F Guilloton5, D Hose6, K Tarte3, B Klein7.   

Abstract

The recent understanding of plasma cell (PC) biology has been obtained mainly from murine models. The current concept is that plasmablasts home to the BM and further differentiate into long-lived PCs (LLPCs). These LLPCs survive for months in contact with a complex niche comprising stromal cells (SCs) and hematopoietic cells, both producing recruitment and survival factors. Using a multi-step culture system, we show here the possibility to differentiate human memory B cells into LLPCs surviving for at least 4 months in vitro and producing immunoglobulins continuously. A remarkable feature is that IL-6 is mandatory to generate LLPCs in vitro together with either APRIL or soluble factors produced by SCs, unrelated to APRIL/BAFF, SDF-1, or IGF-1. These LLPCs are out of the cell cycle, express highly PC transcription factors and surface markers. This model shows a remarkable robustness of human LLPCs, which can survive and produce highly immunoglobulins for months in vitro without the contact with niche cells, providing the presence of a minimal cocktail of growth factors and nutrients. This model should be useful to understand further normal PC biology and its deregulation in premalignant or malignant PC disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504026     DOI: 10.1038/leu.2014.61

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  55 in total

Review 1.  BAFF, APRIL and their receptors: structure, function and signaling.

Authors:  Claudia Bossen; Pascal Schneider
Journal:  Semin Immunol       Date:  2006-08-17       Impact factor: 11.130

2.  A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines.

Authors:  Jérôme Moreaux; Bernard Klein; Régis Bataille; Géraldine Descamps; Sophie Maïga; Dirk Hose; Hartmut Goldschmidt; Anna Jauch; Thierry Rème; Michel Jourdan; Martine Amiot; Catherine Pellat-Deceunynck
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

Review 3.  Pathogenesis of myeloma.

Authors:  Kenneth C Anderson; Ruben D Carrasco
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.

Authors:  J Wijdenes; W C Vooijs; C Clément; J Post; F Morard; N Vita; P Laurent; R X Sun; B Klein; J M Dore
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

Review 5.  The genetic architecture of multiple myeloma.

Authors:  Gareth J Morgan; Brian A Walker; Faith E Davies
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

6.  Blood-borne human plasma cells in steady state are derived from mucosal immune responses.

Authors:  Henrik E Mei; Taketoshi Yoshida; Wondossen Sime; Falk Hiepe; Kathi Thiele; Rudolf A Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.

Authors:  Axel Kallies; Jhagvaral Hasbold; David M Tarlinton; Wendy Dietrich; Lynn M Corcoran; Philip D Hodgkin; Stephen L Nutt
Journal:  J Exp Med       Date:  2004-10-18       Impact factor: 14.307

10.  Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.

Authors:  Alboukadel Kassambara; Matthieu Schoenhals; Jérôme Moreaux; Jean-Luc Veyrune; Thierry Rème; Hartmut Goldschmidt; Dirk Hose; Bernard Klein
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more
  58 in total

1.  APRIL:TACI axis is dispensable for the immune response to rabies vaccination.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Andrew G Lytle; Kishore R Alugupalli; Joseph R Plummer; James P McGettigan
Journal:  Antiviral Res       Date:  2017-06-12       Impact factor: 5.970

2.  Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis.

Authors:  Hsin-Ying Huang; Ana Rivas-Caicedo; François Renevey; Hélène Cannelle; Elisa Peranzoni; Leonardo Scarpellino; Debbie L Hardie; Arnaud Pommier; Karin Schaeuble; Stéphanie Favre; Tobias K Vogt; Fernando Arenzana-Seisdedos; Pascal Schneider; Christopher D Buckley; Emmanuel Donnadieu; Sanjiv A Luther
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

Review 3.  B-cell targeting in chronic graft-versus-host disease.

Authors:  Robert Zeiser; Stefanie Sarantopoulos; Bruce R Blazar
Journal:  Blood       Date:  2018-02-01       Impact factor: 22.113

Review 4.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

5.  Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage.

Authors:  Matthieu Schoenhals; Michel Jourdan; Anja Seckinger; Véronique Pantesco; Dirk Hose; Alboukadel Kassambara; Jérôme Moreaux; Bernard Klein
Journal:  Cell Cycle       Date:  2016-05-26       Impact factor: 4.534

6.  Hypoxia favors the generation of human plasma cells.

Authors:  Matthieu Schoenhals; Michel Jourdan; Angélique Bruyer; Alboukadel Kassambara; Bernard Klein; Jérôme Moreaux
Journal:  Cell Cycle       Date:  2017-05-02       Impact factor: 4.534

7.  Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells.

Authors:  E Steve Woodle; Simon Tremblay; Paul Brailey; Alin Girnita; Rita R Alloway; Bruce Aronow; Nupur Dasgupta; Frederic Ebstein; Peter-Michael Kloetzel; Min Jae Lee; Kyung B Kim; Harinder Singh; James J Driscoll
Journal:  Am J Transplant       Date:  2019-12-11       Impact factor: 8.086

8.  Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation.

Authors:  Sang-Hoon Sin; Sun Ah Kang; Yongbaek Kim; Anthony Eason; Kelly Tan; Hyowon An; Dirk P Dittmer
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

9.  Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.

Authors:  Mandar Bawadekar; Daeun Shim; Chad J Johnson; Thomas F Warner; Ryan Rebernick; Dres Damgaard; Claus H Nielsen; Ger J M Pruijn; Jeniel E Nett; Miriam A Shelef
Journal:  J Autoimmun       Date:  2017-02-07       Impact factor: 7.094

10.  Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.

Authors:  David A Jackson; Timothy D Smith; Nansalmaa Amarsaikhan; Weiguo Han; Matthew S Neil; Shannon K Boi; Anne M Vrabel; Ezequiel J Tolosa; Luciana L Almada; Martin E Fernandez-Zapico; Sherine F Elsawa
Journal:  J Immunol       Date:  2015-08-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.